Literature DB >> 3949762

Substrate-specific forms of human platelet phospholipase A2.

L R Ballou, L M DeWitt, W Y Cheung.   

Abstract

Purification of human platelet phospholipase A2 (PLA2) from a particulate fraction by ion-exchange chromatography at 4 degrees C yielded a single peak of enzyme activity, which catalyzed the hydrolysis of arachidonic acid from the 2-position of phosphatidylcholine (PtdCho) and phosphatidylethanolamine (PtdEtn). The activity toward PtdCho and that toward PtdEtn differed in stability during storage, pH optimum, Ca2+ requirement, and affinity for the substrate; however, each activity preferred phospholipid with arachidonate at the 2-position. The two activities appeared to be eluted as an aggregate in a single peak from the ion-exchange column. When the column was run at 22 degrees C, an additional PLA2 activity peak specific for PtdEtn was resolved from the original PLA2 peak. But when the particulate fraction was briefly sonicated in 0.1% octylglucoside before chromatography at 22 degrees C, a different PLA2 activity peak, specific for PtdCho, was obtained. Resolution of the two specific forms of PLA2 under different conditions probably resulted from selective solubilization of the aggregate. The specific PLA2 activities thus isolated were very labile, whereas those in the aggregate were relatively stable. These findings suggest that human platelets contain at least two substrate-specific forms of PLA2, one for PtdCho and another for PtdEtn.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3949762

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

Review 1.  G protein regulation of phospholipase A2.

Authors:  R M Burch
Journal:  Mol Neurobiol       Date:  1989       Impact factor: 5.590

2.  Primary role of calcium ions in arachidonic acid release from rat platelet membranes. Comparison with human platelet membranes.

Authors:  S Nakashima; A Suganuma; A Matsui; H Hattori; M Sato; A Takenaka; Y Nozawa
Journal:  Biochem J       Date:  1989-04-01       Impact factor: 3.857

3.  Formation of cis-14,15-oxido-5,8,11-icosatrienoic acid from phosphatidylinositol in human platelets.

Authors:  L R Ballou; B K Lam; P Y Wong; W Y Cheung
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

4.  The tyrosine kinase activity of the epidermal-growth-factor receptor is necessary for phospholipase A2 activation.

Authors:  H J Goldberg; M M Viegas; B L Margolis; J Schlessinger; K L Skorecki
Journal:  Biochem J       Date:  1990-04-15       Impact factor: 3.857

5.  Eicosanoid synthesis in duodenal ulcer disease: decrease in leukotriene C4 by colloidal bismuth subcitrate.

Authors:  A Ahmed; P R Salmon; C R Cairns; M Hobsley; J R Hoult
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

6.  Characterization of calcium-independent cytosolic phospholipase A2 activity in the submucosal regions of rat stomach and small intestine.

Authors:  T Fukushima; G Serrero
Journal:  Lipids       Date:  1994-03       Impact factor: 1.880

7.  Group IVA cytosolic phospholipase A2 (cPLA2alpha) and integrin alphaIIbbeta3 reinforce each other's functions during alphaIIbbeta3 signaling in platelets.

Authors:  Nicolas Prévost; John V Mitsios; Hisashi Kato; John E Burke; Edward A Dennis; Takao Shimizu; Sanford J Shattil
Journal:  Blood       Date:  2008-10-07       Impact factor: 22.113

8.  Mobilization of arachidonic acid in collagen-stimulated human platelets.

Authors:  H R Vedelago; V G Mahadevappa
Journal:  Biochem J       Date:  1988-12-15       Impact factor: 3.857

9.  Stimulated cholesterol-enriched platelets display increased cytosolic Ca2+ and phospholipase A activity independent of changes in inositol trisphosphates and agonist/receptor binding.

Authors:  A Sorisky; G L Kucera; S E Rittenhouse
Journal:  Biochem J       Date:  1990-02-01       Impact factor: 3.857

10.  FMLP-induced arachidonic acid release, phospholipid metabolism, and calcium mobilization in human monocytes. Regulation by cyclic AMP.

Authors:  R W Godfrey; R M Manzi; B D Jensen; S T Hoffstein
Journal:  Inflammation       Date:  1988-06       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.